| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |